SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Auxilium Pharmaceuticals Announces Expansion of Its Exclusive License for XIAFLEX® (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication